The petroleum ether and chloroform extracts of the root of Piper chaba showed antimicrobial, antileishmanial and cytotoxic activities. Further bioactivity-guided fractionation led to the isolation of Bornyl piperate (1), piperlonguminine (2) and piperine (3). This is the first report of isolation of compounds (1) and (2) from P. chaba. It was observed that the isolated compounds (1 and 2) showed potent antifungal activity when compared with standard drug Nystatin, and significant cytotoxic activity with the IC₅₀ values of 0.76 and 0.83 µg mL⁻¹, respectively. These compounds were also found to have weak antibacterial and antileishmanial activities. This is the first report about the antileishmanial activity of Piper isolates.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/14786419.2010.535166 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Phenolic compounds, antioxidant and antileishmanial activities of kombucha as affected by fermentation time.
Heliyon
November 2024
Antimicrobial and Biocontrol Agents Unit, Laboratory for Phytobiochemistry and Medicinal Plants Studies, Department of Biochemistry, Faculty of Science University of Yaounde I, P. O Box 812, Yaounde, Cameroon.
Objective: Study the impact of fermentation time on the phytochemical properties, antioxidant and antileishmanial activities.
Materials And Methods: The preparation of Kombucha tea by fermentation was performed under aseptic conditions and symbiotic culture of bacteria and yeast (SCOBY) layer was maintained in culture for continuous growth in a water-sugar (4 L-500 g) mixture for 7, 14, 21, 28 and 35 days. The process of preparation was performed using a decoction.
In Vitro Antileishmanial and Immune Modulation of Trigonelline Against Leishmania major.
Parasite Immunol
December 2024
Department of Epidemiology and Biostatistics, Shahrekord University of Medical Sciences, Shahrekord, Iran.
The mechanistic study of new pharmaceutical compounds is crucial for evaluating their efficacy, identifying potential side effects, and optimising drug formulations. This study aimed to investigate the mechanism of action of trigonelline on the promastigote and amastigote stages of Leishmania major (MRHO/IR/75/ER). An initial in silico study was conducted to examine the pharmacological effects of trigonelline using molecular docking to evaluate the potential binding affinity of trigonelline with nitrate, a crucial molecule in the macrophage immune response against Leishmania.
View Article and Find Full Text PDFBrominated chalcones as promising antileishmanial agents.
Bioorg Med Chem Lett
February 2025
Departamento de Química, Universidade Federal de Sergipe, Aracaju, Brazil.
Leishmaniasis is a group of diseases caused by protozoa of the genus Leishmania. They are considered neglected diseases and are endemic to tropical and subtropical regions, affecting thousands of people annually. Leishmaniasis has a wide global distribution, present on four continents.
View Article and Find Full Text PDFEnhancing Antileishmanial Activity of Amidoxime-Based Compounds Bearing a 4,5-Dihydrofuran Scaffold: In Vitro Screening Against .
Molecules
November 2024
Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, 27 Boulevard Jean Moulin, CS30064, CEDEX 05, 13385 Marseille, France.
Article Synopsis
- - Leishmaniasis, caused by a protozoan, has treatment gaps, leading to the development of new amidoxime derivatives aimed at improving antileishmanial activity.
- - Twelve new compounds were created by modifying a previous hit, using a three-step synthesis process that included cyclization, amidation, and reaction with hydroxylamine.
- - Three specific derivatives showed promising in vitro toxicity-activity results, with high selectivity indices (SI) against the parasite, indicating they could potentially be more effective and less toxic than existing treatments like Pentamidine.
Formulation, in vitro evaluation and therapeutic effect of chitosan coated pluronic F127 micelles containing miltefosine for the treatment of visceral leishmaniasis in domestic dogs naturally infected by Leishmania infantum.
Res Vet Sci
January 2025
Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- * The researchers tested the new Cs/PF/MTF formulation's effectiveness against both the parasite stages in vitro and in vivo on naturally infected dogs, finding it significantly more potent than standard miltefosine.
- * The new formulation was well-tolerated in dogs, with successful intravenous doses of 170 μg/kg administered daily for 28 days, indicating potential for improved treatment outcomes in CVL.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!